BioAtla Inc Forecast, price target & analysts
$0.51
24.69%
yesterday
Nasdaq,
Jun 02, 10:09 pm CET
BioAtla Inc Target price 2025 - Analyst rating & recommendation
Powered by
BioAtla Inc Classifications & Recommendation:
Buy
67%
Hold
33%
BioAtla Inc Price Target
| Target Price | $5.50 |
| Price | $0.51 |
| Potential |
978.43%
register free of charge
|
| Number of Estimates | 2 |
|
2 Analysts have issued a price target BioAtla Inc 2026 .
The average BioAtla Inc target price is $5.50.
This is
978.43%
register free of charge
$10.00
1,860.78%
register free of charge
$1.00
96.08%
register free of charge
|
|
| A rating was issued by 3 analysts: 2 Analysts recommend BioAtla Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the BioAtla Inc stock has an average upside potential 2026 of
978.43%
register free of charge
|
Current BioAtla Inc Upgrades & Downgrades
Create a Premium account to unlock Upgrades/Downgrades.
Learn more
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Citizens Capital Markets |
Locked
➜
Locked
|
Locked | Mar 31 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 31 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 13 2024 |
| JMP Securities |
Locked
➜
Locked
|
Locked | Sep 16 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Citizens Capital Markets:
Locked
➜
Locked
|
Mar 31 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 31 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 13 2024 |
|
Locked
JMP Securities:
Locked
➜
Locked
|
Sep 16 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
